Site Search
Site Search
Displaying results 251 - 260 of 893
Socio-economic legacy: the European Lead Factory
The European Lead Factory is a collaborative public-private partnership that delivers innovative drug discovery starting points.
![ideas](/sites/default/files/styles/project_teaser_image/public/uploads/images/news-events/Newsroom/blackboard%20bulb%20pexels.jpg?itok=xLqAgK-d)
Got COVID-19 patient data? Want to collaborate? IMI’s EHDEN project can help you standardise it.
EHDEN is offering to harmonise organisations’ clinical data to a standard model, while preserving patients’ privacy. This will make it easier to aggregate and jointly analyse data from different sources, something that is essential if we are to stop the outbreak and save lives.
![The SARS-CoV-2 virus. Credit NIAID-RML](/sites/default/files/styles/project_teaser_image/public/news/SARS-CoV-2%20virus%20emerging%20from%20cells%20in%20the%20lab%20Credit%20NIAID-RML.jpg?itok=LuIPX-LQ)
Socio-economic legacy: GetReal's real-world resonance
IMI project GetReal and its follow-up, GetReal Initiative, show new methods of RWE collection and synthesis could be adopted earlier in pharmaceutical R&D and the healthcare decision making process.
![data by pixabay](/sites/default/files/styles/project_teaser_image/public/uploads/images/news-events/Newsroom/data%20pixabay%20public%20domain.jpg?itok=UA2HN7Zr)
Addressing the impacts of COVID-19 on IMI Calls and projects
At the IMI Programme Office, we are very conscious of the fact that the COVID-19 outbreak poses significant challenges for IMI projects and applicants alike. Here we summarise the steps taken at IMI to mitigate the situation, and provide links to resources that may be helpful ...
INNODIA set to speed up clinical trials for type 1 diabetes drugs
The INNODIA project’s clinical trial master protocol means launching new clinical trials for drugs to cure type 1 diabetes will be faster and easier.
Draft future Call topics published online
Tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare disease diagnosis, clinical trial data, and patient adherence are the topics proposed for IMI’s next Calls for proposals.
![Close up of a hand holding a tiny lightbulb. Credit: Shutterstock](/sites/default/files/styles/project_teaser_image/public/news/shutterstock_569385067.jpg?itok=orr0PvzF)
ECSEL JU calls for input on planned Call for proposals on decentralised clinical trials
ECSEL JU, the joint undertaking for electronic components and systems, has launched a ‘Call for Vision’ for a planned Call for proposals that would complement the work of IMI’s Trials@Home project.
![Smart watch - image by Fancycrave1 from Pixabay](/sites/default/files/styles/project_teaser_image/public/news/smart-watch-Image%20by%20fancycrave1%20from%20Pixabay.jpg?itok=YLIcIdxg)
Focus on: socio-economic impact of IMI projects
In April, it's IMI's birthday, 12 years and 150 projects later, what kind of socio-economic impact has IMI-funded research had?
![Impact](/sites/default/files/styles/project_teaser_image/public/uploads/images/news-events/Newsroom/Engineer%20image%20by%20RAEng_Publications%20via%20Pixabay%20no%20attrib.jpg?itok=9y0aSKKE)
IMI networks are helping set up and run COVID-19 drug trials
IMI’s COMBACTE project is perfectly placed to support the DisCoVery studies of four potential COVID-19 therapies
![SARS-COV-2](/sites/default/files/styles/project_teaser_image/public/uploads/images/news-events/Newsroom/SARS-COV-2%20NIH%20Public%20Domain.jpg?itok=MrWkdqwE)